Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.

Huang WC, Tsai TH, Chuang LT, Li YY, Zouboulis CC, Tsai PJ.

J Dermatol Sci. 2014 Mar;73(3):232-40. doi: 10.1016/j.jdermsci.2013.10.010. Epub 2013 Nov 7.

PMID:
24284257
[PubMed - indexed for MEDLINE]
2.

Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM.

J Invest Dermatol. 2009 Oct;129(10):2480-8. doi: 10.1038/jid.2009.93. Epub 2009 Apr 23.

PMID:
19387482
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways.

Grange PA, Raingeaud J, Calvez V, Dupin N.

J Dermatol Sci. 2009 Nov;56(2):106-12. doi: 10.1016/j.jdermsci.2009.08.001. Epub 2009 Sep 1.

PMID:
19726162
[PubMed - indexed for MEDLINE]
4.

Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.

Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang CM.

J Invest Dermatol. 2010 Apr;130(4):985-94. doi: 10.1038/jid.2009.384. Epub 2009 Dec 24.

PMID:
20032992
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rosmarinus officinalis extract suppresses Propionibacterium acnes-induced inflammatory responses.

Tsai TH, Chuang LT, Lien TJ, Liing YR, Chen WY, Tsai PJ.

J Med Food. 2013 Apr;16(4):324-33. doi: 10.1089/jmf.2012.2577. Epub 2013 Mar 20.

PMID:
23514231
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.

Pornpattananangkul D, Fu V, Thamphiwatana S, Zhang L, Chen M, Vecchio J, Gao W, Huang CM, Zhang L.

Adv Healthc Mater. 2013 Oct;2(10):1322-8. doi: 10.1002/adhm.201300002. Epub 2013 Mar 12.

PMID:
23495239
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo.

Lee WR, Kim KH, An HJ, Kim JY, Chang YC, Chung H, Park YY, Lee ML, Park KK.

J Invest Dermatol. 2014 Jul;134(7):1922-30. doi: 10.1038/jid.2014.75. Epub 2014 Feb 4.

PMID:
24496237
[PubMed - indexed for MEDLINE]
8.

Inhibitory effect of chlorophyllin on the Propionibacterium acnes-induced chemokine expression.

Kang MS, Kim JH, Shin BA, Lee HC, Kim YS, Lim HS, Oh JS.

J Microbiol. 2013 Dec;51(6):844-9. doi: 10.1007/s12275-013-3015-y. Epub 2013 Dec 19. Erratum in: J Microbiol. 2014 Feb;52(2):184.

PMID:
24385363
[PubMed - indexed for MEDLINE]
9.

Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids.

Ko HL, Heczko PB, Pulverer G.

J Invest Dermatol. 1978 Dec;71(6):363-5.

PMID:
722112
[PubMed - indexed for MEDLINE]
10.

CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.

Lee YJ, Choi HJ, Kang TW, Kim HO, Chung MJ, Park YM.

J Microbiol Biotechnol. 2008 Jul;18(7):1308-16.

PMID:
18667861
[PubMed - indexed for MEDLINE]
Free Article
11.

Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.

Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D.

Planta Med. 2005 Apr;71(4):338-43.

PMID:
15856410
[PubMed - indexed for MEDLINE]
12.

Antibacterial and anti-inflammatory effects of Syzygium jambos L. (Alston) and isolated compounds on acne vulgaris.

Sharma R, Kishore N, Hussein A, Lall N.

BMC Complement Altern Med. 2013 Oct 29;13:292. doi: 10.1186/1472-6882-13-292.

PMID:
24168697
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes.

Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, Urabe K, Furue M.

J Dermatol Sci. 2002 Aug;29(2):97-103.

PMID:
12088610
[PubMed - indexed for MEDLINE]
14.

The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.

Yang D, Pornpattananangkul D, Nakatsuji T, Chan M, Carson D, Huang CM, Zhang L.

Biomaterials. 2009 Oct;30(30):6035-40. doi: 10.1016/j.biomaterials.2009.07.033. Epub 2009 Aug 8.

PMID:
19665786
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus.

Desbois AP, Lawlor KC.

Mar Drugs. 2013 Nov 13;11(11):4544-57. doi: 10.3390/md11114544.

PMID:
24232668
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.

Weiss T, Shalit I, Blau H, Werber S, Halperin D, Levitov A, Fabian I.

Antimicrob Agents Chemother. 2004 Jun;48(6):1974-82.

PMID:
15155187
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-κB and AP-1 activation in macrophages.

Tsai HH, Lee WR, Wang PH, Cheng KT, Chen YC, Shen SC.

J Dermatol Sci. 2013 Feb;69(2):122-31. doi: 10.1016/j.jdermsci.2012.10.009. Epub 2012 Oct 24.

PMID:
23178030
[PubMed - indexed for MEDLINE]
18.

Hexane fraction from Sargassum fulvellum inhibits lipopolysaccharide-induced inducible nitric oxide synthase expression in RAW 264.7 cells via NF-κB pathways.

Gwon WG, Lee MS, Kim JS, Kim JI, Lim CW, Kim NG, Kim HR.

Am J Chin Med. 2013;41(3):565-84. doi: 10.1142/S0192415X13500407.

PMID:
23711142
[PubMed - indexed for MEDLINE]
19.

Anti-inflammatory effect of tetrahydrocoptisine from Corydalis impatiens is a function of possible inhibition of TNF-α, IL-6 and NO production in lipopolysaccharide-stimulated peritoneal macrophages through inhibiting NF-κB activation and MAPK pathway.

Li W, Huang H, Zhang Y, Fan T, Liu X, Xing W, Niu X.

Eur J Pharmacol. 2013 Sep 5;715(1-3):62-71. doi: 10.1016/j.ejphar.2013.06.017. Epub 2013 Jun 25.

PMID:
23810685
[PubMed - indexed for MEDLINE]
20.

Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.

Joh EH, Kim DH.

Br J Pharmacol. 2011 Apr;162(8):1731-42. doi: 10.1111/j.1476-5381.2010.01195.x.

PMID:
21198552
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk